Use of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Hospital Setting
Authors:
- 1 November 2005
- journal article
- research article
- Published by SAGE Publications in The Diabetes Educator
- Vol. 31 (6) , 849-857
Abstract
Purpose Individuals whose diabetes is being treated in the outpatient setting via an insulin pump often wish to maintain this therapy during hospitalization. The authors propose guidelines for management of patients on insulin pumps who require a hospital admission. Methods A collaborative interinstitutional task force reviewed current available information regarding the use of insulin pumps in the hospital. Results There was little information in the medical literature on how to manage individuals on established insulin pump therapy during a hospital stay. The task force believed that a policy that promotes patient independence through continuation of insulin pump therapy while ensuring patient safety was possible. A set of contraindications for continued use of pump therapy in the hospital are proposed. A sample patient consent form and order set are presented. Finally, measures that can be used to assess effectiveness of an inpatient insulin pump policy are outlined. Conclusions Patients on established insulin pump therapy do not necessarily have to discontinue treatment while hospitalized. However, clear policies and procedures should be established at the institutional level to guide continued use of the technology in the acute care setting.Keywords
This publication has 7 references indexed in Scilit:
- Current Perspectives on the Use of Continuous Subcutaneous Insulin Infusion in the Acute Care Setting and Overview of TherapyCritical Care Nursing Quarterly, 2004
- American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic ControlEndocrine Practice, 2004
- Multiple Hospitalizations for Patients With DiabetesDiabetes Care, 2003
- Economic Costs of Diabetes in the U.S. in 2002Diabetes Care, 2003
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993